Menstrual cycle and oral contraceptive use do not modify postexercise heat loss responses.
It is unknown whether menstrual cycle or oral contraceptive (OC) use influences nonthermal control of postexercise heat loss responses. We evaluated the effect of menstrual cycle and OC use on the activation of heat loss responses during a passive heating protocol performed pre- and postexercise. Women without OC (n = 8) underwent pre- and postexercise passive heating during the early follicular phase (FP) and midluteal phase (LP). Women with OC (n = 8) underwent testing during the active pill consumption (high exogenous hormone phase, HH) and placebo (low exogenous hormone phase, LH) weeks. After a 60-min habituation at 26 degrees C, subjects donned a liquid conditioned suit. Mean skin temperature was clamped at approximately 32.5 degrees C for approximately 15 min and then gradually increased, and the absolute esophageal temperature at which the onset of forearm vasodilation (Th(vd)) and upper back sweating (Th(sw)) were noted. Subjects then cycled for 30 min at 75% Vo(2 peak) followed by a 15-min seated recovery. A second passive heating was then performed to establish postexercise values for Th(vd) and Th(sw). Between 2 and 15 min postexercise, mean arterial pressure (MAP) remained significantly below baseline (P < 0.05) by 10 +/- 1 and 11 +/- 1 mmHg for the FP/LH and LP/HH, respectively. MAP was not different between cycle phases. During LP/HH, Th(vd) was 0.16 +/- 0.24 degrees C greater than FP/LH preexercise (P = 0.020) and 0.15 +/- 0.23 degrees C greater than FP/LH postexercise (P = 0.017). During LP/HH, Th(sw) was 0.17 +/- 0.23 degrees C greater than FP/LH preexercise (P = 0.016) and 0.18 +/- 0.16 degrees C greater than FP/LH postexercise (P = 0.001). Postexercise thresholds were significantly greater (P < or = 0.001) than preexercise during both FP/LH (Th(vd), 0.22 +/- 0.03 degrees C; Th(sw), 0.13 +/- 0.03 degrees C) and LP/HH (Th(vd), 0.21 +/- 0.03 degrees C; Th(sw), 0.14 +/- 0.03 degrees C); however, the effect of exercise was similar between LP/HH and FP/LH. No effect of OC use was observed. We conclude that neither menstrual cycle nor OC use modifies the magnitude of the postexercise elevation in Th(vd) and Th(sw).
Kenny
Glen P
GP
University of Ottawa, School of Human Kinetics, 125 University, Ottawa, Ontario, Canada. gkenny@uottawa.ca
Leclair
Emily
E
Sigal
Ronald J
RJ
Journeay
W Shane
WS
Kilby
Donald
D
Nettlefold
Lindsay
L
Reardon
Francis D
FD
Jay
Ollie
O
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D001833:Body Temperature Regulation / Q000187:drug effects*; D003276:Contraceptives, Oral / Q000009:adverse effects / Q000494:pharmacology*; D015444:Exercise; D005260:Female; D012739:Gonadal Steroid Hormones / Q000378:metabolism*; D006358:Hot Temperature; D006801:Humans; D007022:Hypotension / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D008597:Menstrual Cycle / Q000187:drug effects* / Q000378:metabolism; D012867:Skin / Q000098:blood supply; D013546:Sweating / Q000187:drug effects*; D013997:Time Factors; D014664:Vasodilation / Q000187:drug effects
D003276:Contraceptives, Oral; D012739:Gonadal Steroid Hormones